We ask Christopher Kope, president of National Drug Manufacturers, about the impact of biological drugs on medical progress.
Medexpress: We are hearing more and more about therapies with biological, bioequivalent drugs. In a few words, can you give an overview of what these drugs are and their impact on medical progress?
K.K.: Biologic treatment is a breakthrough. I would like to deny the division - there is no reference biological treatment and biological treatment with bioequivalent drugs. We treat with biologic drugs all the time. The division exists only in the realm of registration. First there was one product, and after twenty y...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
